sglt2 glp 1 Perspectives in weight control in diabetes – inhibitors and GLP-1–glucagon dual agonism GLP1 Receptor Agonists vs SGLT2-I

Jacques et al

Its unknown at this time how long people will stay on this, given some of the very serious side effects

[DOI] [PMC free article] [PubMed] [Google Scholar] 34.Samson S.L., Bajaj M

Long-Term GLP-1 Outcomes The first 2 weeks of GLP-1 therapy set expectations for the journey ahead, but early appetite changes don't always predict final weight loss magnitude

But the mechanistic data is compelling enough that several research groups are exploring this avenue

For a person with diabetes, were going to get a big one-two punch with Wegovy because its highly effective for controlling diabetes and helping with weight loss, Lazarus explains